Transcriptomics Market Witnesses A Growth Of Cagr 20.11% During 2021-2031 - Bis Research

By Author: BIS Research
Total Articles: 68
Comment this article

The growth of the transcriptomics market is expected to be driven by the decrease in the cost of sequencing, the global increase in the application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of the products. However, there are significant challenges restraining the market growth, such as the high cost and maintenance of next-generation sequencing and RNA sequencing platforms and the lack of tools for computational analysis. The transcriptomics approach has been able to decipher the mechanism of complex bulk tissue, giving a deep understanding of heterogeneous cell populations. With the co-analysis of molecules, such as RNA, and protein, at a single cell level, the researchers are able to unearth the regulation mechanism associated with RNA transcription and protein translation.
The healthcare experts have found the Transcriptomics Market to be one of the stable markets, and the market is predicted to grow at a CAGR of 20.11% during the forecast period 2021-2031.
The transcriptomics market is an emerging market with huge growth potential. Recent technological advancements ...
... are facilitating the adoption of the technology at a rapid pace. Transcriptomics offers the ability to isolate a single cell with specific phenotypes from a heterogeneous mixture, along with gene expression analysis and protein expression analysis. The unique feature of transcriptomics technology to integrate the data from various molecules and from different cells to study cell-to-cell differentiation enables the study of mechanisms that are visible at a transcriptomic level.
Competitive Landscape
The growth in this market is expected to be driven by the decrease in the cost of sequencing, the global increase in the application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches. The growth of other technologies, such as in-situ hybridization, can be attributed to the increased clinical research to understand the involvement of molecular pathology in the diagnosis and prognosis of genetic disorders. Based on region, North America holds the largest share in the market, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.
Which are the top market players operating in the global transcriptomics market?
The top market players are 10x Genomics, Agilent Technologies, Inc., ANGLE plc, Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., Bio-Techne, BioSypder, Inc., Cytiva, Fluidigm Corporation, Illumina, Inc., Menarini Silicon Biosystems, NanoString, Pacific Biosciences of California, Inc., PerkinElmer Inc., QIAGEN, Takara Bio Inc.Thermo Fisher Scientific Inc.
What are some of the opportunities in the transcriptomics market?
The potential opportunities that are likely to boost the growth of the market include expansion into new research application, expansion of biomarker discovery and use of toxicogenomic to promote transcriptomics research.
To Read more visit:
https://bisresearch.com/industry-report/transcriptomics-market.html